7-oxabicycloheptane-substituted oxa prostaglandin analogs and th

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

549463, A61K 3134, C07D30700

Patent

active

045887438

ABSTRACT:
7-Oxabicycloheptane substituted oxa prostaglandin analogs are provided having the structural formula ##STR1## wherein R is OH, ##STR2## (wherein R.sup.3 is lower alkyl, aryl, arylalkyl or lower alkylamino), ##STR3## (wherein R.sup.4 and R.sup.5 are the same or different and can be H, alkyl, aryl or arylalkyl, and R.sup.6 is alkyl or O-alkyl); R.sup.1 is lower alkyl, aryl, aralkyl, cycloalkyl or cycloalkylalkyl; R.sup.2 is hydrogen or lower alkyl; A is --CH.dbd.CH-- or --(CH.sub.2).sub.2 --; n is 1 to 4, and m is 1 to 8, and including all stereoisomers thereof.
The compounds are cardiovascular agents useful, for example, in the treatment of thrombotic disease.

REFERENCES:
patent: 4143054 (1979-03-01), Sprague
patent: 4187236 (1980-02-01), Sprague
patent: 4220594 (1980-09-01), Sprague
patent: 4228180 (1980-10-01), Sprague
patent: 4254044 (1981-03-01), Sprague

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

7-oxabicycloheptane-substituted oxa prostaglandin analogs and th does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 7-oxabicycloheptane-substituted oxa prostaglandin analogs and th, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-oxabicycloheptane-substituted oxa prostaglandin analogs and th will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1770381

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.